assurance maladie maternité – La non-prise en charge des anticorps monoclonaux anti-CGRP

This written question asks about the non-reimbursement of anti-CGRP monoclonal antibodies under the French health insurance system. It seeks clarification on the reasons behind this decision and its impact on patients. The question concerns patients suffering from migraines who might benefit from these treatments. It highlights a potential gap in healthcare coverage for specific innovative therapies.